Genetron Holdings Ltd GTH:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/25/21 EST
26.17quote price arrow up+0.19 (+0.73%)
Volume
827,218
52 week range
9.03 - 31.54

...

Loading . . .

KEY STATS

  • Open26.68
  • Day High27.50
  • Day Low25.77
  • Prev Close26.17
  • 52 Week High31.54
  • 52 Week High Date02/16/21
  • 52 Week Low9.03
  • 52 Week Low Date09/24/20
  • Market Cap2.312B
  • Shares Out88.36M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-15.60
  • P/E (TTM)-1.68
  • Fwd P/E (NTM)-61.00
  • EBITDA (MRQ)-40.303M
  • ROE (MRQ)-2,433.48%
  • Revenue (MRQ)60.95M
  • Gross Margin (MRQ)56.40%
  • Net Margin (MRQ)-795.62%
  • Debt To Equity (MRQ)6.24%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Genetron Holdings Ltd News

There is no recent news for this security.

Latest GTH News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Genetron Holdings Limited is a precision oncology company that specializes in cancer molecular profiling and harnesses technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive product and service portfolio that cover the full-cycle of cancer care from early screening, to diagnosis and treatment recommendations, to continuous monitoring and continuous care. The Company operates its businesses primarily within...
Address
Beijing, BEJ
102206
China